Human Lymphatic Endothelial Cells Expressing NRASQ61R Model Characteristics of Kaposiform Lymphangiomatosis
Open Access
- 18 August 2025
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (11) , e31984
Abstract
Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly characterized by lymphatic overgrowth and dysfunction. The goal of this study was to determine how the NRASQ61R variant found in the tissue of KLA patients impacts key characteristics of lymphatic endothelial cells (LEC). LEC expressing NRASQ61R had a spindled morphology, increased migration, increased proliferation, increased MAPK signaling, and elevated angiopoietin‐2 production. In an in vitro lymphangiogenesis model, LEC expressing NRASQ61R showed increased sprouting and formed enlarged and disorganized vascular structures. This model of LEC expressing NRASQ61R can be used to give insights into KLA pathogenesis and test new treatments.Keywords
This publication has 18 references indexed in Scilit:
- RAS Pathway Mutations and Therapeutics in Vascular AnomaliesPediatric Blood & Cancer, 2025
- NRAS Q61R mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse modelPediatric Blood & Cancer, 2024
- Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatmentPediatric Blood & Cancer, 2023
- NRASQ61R mutation in human endothelial cells causes vascular malformationsAngiogenesis, 2022
- Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibitionPediatric Research, 2022
- Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entityHuman Pathology, 2022
- Potential biomarkers of kaposiform lymphangiomatosisPediatric Blood & Cancer, 2019
- A somatic activating NRAS variant associated with kaposiform lymphangiomatosisGenetics in Medicine, 2018
- Angiopoietins as serum biomarkers for lymphatic anomaliesAngiogenesis, 2016
- Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic AnomalyThe Journal of Pediatrics, 2014